|
| Home : Cardiome Pharma Corp. Announces Approximately US$15.0 Million Bought Deal Financing |
|
Jul 29
2015 |
Cardiome Pharma Corp. Announces Approximately US$15.0 Million Bought Deal Financing |
|
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 28, 2015) - Cardiome Pharma Corp. ("Cardiome" or the "Company") (NASDAQ:CRME)(TSX:COM) announced today that it has entered into an agreement with a syndicate of underwriters led by Cormark Securities Inc., acting as sole bookrunner and co-lead underwriter and Canaccord Genuity Corp., acting as co-lead underwriter and including Brean Capital LLC and Laurentian Bank Securities Inc. (collectively, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 1,875,000 common shares from the treasury of the Company (the "Shares") at a price of US$8.00 per share (the "Offering Price"), for gross proceeds of approximately US$15.0 million (the "Offering"). |
|
|
|
| Source:http://www.marketwired.com/mw/release.do?id=2042657&sourceType=3 |
| |
|
Related News
|
» Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock
» Tricon Capital Group Announces New Strategic Initiative, Tricon Luxury Residences, and Bought Deal Equity Financing
|
|
|
